Fas is a cell surface protein that mediates apoptosis. A mouse mutant, Ipr (lymphoproliferation), has a mutation in the Fas gene. In this report, we studied the expression and function of Fas in various subpopulations of mouse thymocytes. Abundant expression of Fas was detected on CD4+CD8 + double positive as well as CD4 § or CD8 + single positive thymocytes in wildtype mice. Little or low levels of Fas were expressed in CD4-CD8-double negative thymocytes except for the CD4-CD8-CD3 § phenotype, which expresses Fas as abundantly as double positive or single positive subsets. On the other hand, no Fas expression was detected in any population of thymocytes from Ipr mice. When the wild-type thymocytes were treated with the agonistic anti-Fas antibody, double positive cells from the wild-type mice were selectively killed by apoptosis, whereas, the single positive cells were resistant to its cytolytic activity despite their abundant expression of Fas. Unlike the apoptosis of thymocytes induced by glucocorticoid or T cell activator, the Fas-induced apoptosis of thymocytes was enhanced by metabolic inhibitors such as cycloheximide. Furthermore, intraperitoneal administration of the anti-Fas antibody into mice caused rapid apoptosis of thymocytes in vivo.
T lymphocytes respond to a wide variety of foreign antigens, whereas they do not respond to self components. This repertoire of T cells are generated during their development in the thymus (1) . The interaction of immature CD3 +/low CD4 + CD8 + thymocytes with epithelial stroma cells in the thymus induces positive selection of T cells, in which T cells recognizing the self-MHC as recognition elements are positively selected and leave the thymus for the periphery (2) . The T cells which do not undergo positive selection die by apoptosis. The immature thymocytes are also subject to negative selection in which the high avidity interaction of thymocytes with the thymic stromal cells eliminates the T cells that are potentially autoreactive (3) . This process is called clonal deletion and proceeds by apoptosis. In addition to the selection mechanism in the thymus, mature T cells recognizing the self-components are extrathymically eliminated by apoptosis (4) .
The Fas antigen (Fas) is a cell-surface protein with molecular mass of 45 kD, and it belongs to the TNF/nerve growth factor (NGF) 1 receptor family (5-7). Since agonistic anti-Fas antibodies or Fas ligand can induce apoptosis under most circumstances (8) (9) (10) (11) (12) , the Fas ligand and Fas can be regarded as a death factor and its receptor (7) . Fas is expressed in various tissues such as the thymus, liver, heart and ovary (5) , whereas the Fas ligand is abundant in activated splenocytes and the testis (9) . Chromosomal mapping and molecular analyses of the Fas and Fas ligand genes have indicated that mouse mutants, lymphoproliferation (lpr) and generalized lymphoproliferative disease (gtd) carry mutations in the Fas and Fas ligand, respectively (13) (14) (15) . Mice homozygous for these mutations have similar phenotypes (16) . They accumulate a large number of abnormal T lymphocytes (CD4-CD8-) in the lymph nodes and spleen, and suffer from autoimmune disease by producing autoantibody. Since lpr and gld are loss-offunction mutations of Fas and Fas ligand, these phenotypes indicate that the Fas and Fas ligand system is involved in the deletion process of autoreactive T cells.
To examine the expression and function of Fas in mice, we established an agonistic monoclonal antibody against mouse Fas that has cytotoxic activity in vitro and in vivo (8) . In this report, we examined the Fas expression of mouse thymocytes and their sensitivity to the cytotoxic activity of the antibody. Although most thymocytes except for the CD3-CD4-CD8 -subpopulation uniformly express Fas, only CD4+CD8 + double positive (DP) thymocytes were susceptible to the cytotoxic activity of the anti-Fas antibody.
clonal antibody was purified from the cultured supernatant by affinity chromatography on protein A-Sepharose as described (8) . In some cases, the antibody was used after biotinylation (8 The DN thymocytes (CD4-CD8-) were divided into CD3-(R1 region) or CD3 + (R2 region) population (left), and the Fas expression in each population was examined (right). 486 Sdective Apoptosis of Double Positive Thymocytes by Anti-Fas Antibody with streptavidin-conjugated TRI-COLOK at 4~ for 30 min. The cells were then washed twice with staining solution, suspended in 400 #1 of the same solution containing 5 #g/ml of propidium iodide, and analyzed by flow cytometry. Three-color flow cytometry was performed on a FACScan | (Becton Dickinson) equipped with a 488-nm argon laser. Data from 5,000 or more cells were collected and analyzed on a FACScan | using LYSIS II software.
Cell Killing Assay. Thymocytes (2 • 10 6 cells) were incubated for various periods at 37~ with the purified Jo2 antibody in 0.5 ml of RPMI 1640 medium containing 10% FCS. The cells were washed once with KPMI 1640 medium, and the dead cells were quantified by flow cytometry after staining with 5 #g/ml propidium iodide. To examine the DNA degradation, chromosomal DNA was prepared from the thymocytes using a SepaGene kit from Sanko Junyaku (Tokyo, Japan), and analyzed on an agarose gel in Trisborate buffer (17) .
Results

Expression of Fas in Mouse Thymocytes.
We previously established a hamster hybridoma (.1o2) producing anti-mouse Fas monodonal antibody, and showed that more than 95% of mouse thymocytes abundantly express Fas (8) . In contrast, (18, 19) . Each subpopulation of thymocytes was then examined for the Fas expression. Double and single positive thymocytes from the wild-type mice uniformly express Fas, and its intensity was almost identical between the two populations. On the other hand, DN thymocytes hardly expressed Fas except for a minor subpopulation. This Fas-positive CD4-CD8-subpopulation was found to be CD3 positive (Fig. 1 c) (8) . To examine whether this antibody has cytotoxic activity on mouse thymocytes, thymocytes were incubated with various concentrations of the purified anti-Fas antibody at 37~ for 16 h in the presence of 30 #g/ml of cycloheximide. As shown in Fig. 2 a, the thymocytes from wild-type mice were killed by anti-Fas antibody in a dose-dependent manner. On the other hand, the antibody did not have any effect on the thymocytes from CBAIprq/lpr cg, which express nonfunctional Fas on the cell surface (13) . Fig. 2 b shows the kinetics of the thymocyte death process by anti-Fas antibody. The thymocytes from the wildtype mice were rapidly killed by anti-Fas antibody, and '~80% of them were dead after a 24-h incubation with 1.0 #g/ml of the anti-Fas antibody. On the other hand, when the thymocytes from CBA-Iprc~/lprcg were incubated with anti-Fas antibody, most cells were still alive under the same conditions. To confirm that the death of the thymocytes induced by antiFas antibody occurred by apoptosis, chromosomal DNA was prepared from the thymocytes after incubation with anti-Fas antibody, and analyzed by agarose gel electrophoresis. As shown in Fig. 3 , chromosomal DNA was fragmented after a 3-h incubation with anti-Fas antibody. After 6 h, most of the chromosomal DNA was degraded in the step ladder fashion that is characteristic of apoptosis. As a control, thymocytes from the wild-type mice were treated for 6 h with the anti-487 Ogasawara et al. CD5 antibody. This treatment did not cause any degradation of chromosomal D N A (Fig. 3) . Apoptosis of thymocytes can be induced by various agents such as glucocorticoids or thymocyte activators (20) (21) (22) (23) (24) . To characterize the apoptosis of thymocytes induced by anti-Fas antibody, and to distinguish it from apoptosis induced by other agents, the thymocytes were incubated for 18 h with either anti-Fas antibody, dexamethasone or a combination of PMA and A23187 ionomycin. Both dexamethasone and PMA/ionomycin rapidly induced apoptosis of the thymocytes, and about 80% of them were dead after 18 h (Fig. 4) . Dexamethasone or PMA/ionomycin also killed the thymocytes from Ipr'e/Iprce mice as efficiently as the wild-type thymocytes, but Jo2 did not induce apoptosis in the Fas-defective Iprce/lprce strain (Fig. 4) . Furthermore, as previously reported (20) (21) (22) (23) (24) , the apoptosis induced by dexamethasone or PMA/ionomycin was almost completely inhibited by cycloheximide, whereas it enhanced the apoptosis induced by antiFas antibody. at 37~ for 16 h with various concentrations of Jo2 antibody in the presence of 30/zg/ml of cycloheximide, and the viable cells were analyzed by flow cytometry using anti-CD4 and CD8 antibody. As shown in Fig. 5 , the DP thymocytes were sensitive to the cytotoxic activity of the Jo2 antibody, and more than half of the DP thymocytes were killed within 16 h by the antibody at a concentration of 100 ng/ml. On the other hand, the viability of either CD4 *CD8-or CD4-CD8 § SP cells did not change after incubation with 1 #g/ml anti-Fas antibody. These results indicated that the SP thymocytes are resistant to Fas-induced apoptosis, although they express Fas as abundantly as CD4 +CD8 + DP thymocytes.
DP but Not SP Thymocytes Are Sensitive to Fas-Induced
In Vivo Apoptosis of Thymocytes by Anti-Fas Antibody. We
showed that mice given an intraperitoneal injection of antiFas antibody rapidly died (8) . Although this administration caused acute hepatic failure, we could not detect any histological abnormality in the thymus 2 h after injection of the antibody. Since the thymocytes were sensitive to the cytotoxic activity of the antibody in vitro, we reexamined the in vivo effect of the antibody on the thymus. As previously found, when 100/zg of the purified Jo2 antibody was intraperitoneally injected into the wild-type mice, most of them died within 3 h, but some survived for 6-7 h (8). Therefore, the thymus was removed at various intervals after injection with Jo2 antibody, and its chromosomal DNA was analyzed on an agarose gel electrophoresis. As shown in Fig. 6 , the thymic DNA was partially fragmented at 3 h after injection DNAs were analyzed by dectrophoresis on a 1% agarose gel in TBE buffer containing 0.5 #g/ml of ethidium bromide. The thymic DNA prepared from the wild-type mice at 5 h after injection of the same amount of the control hamster IgG (lane 7) or anti-CD5 antibody (lane 9) was also analyzed.
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Selective Apoptosis of Double Positive Thymocytes by Anti-Fas Antibody with the antibody, and most DNA was degraded in a step ladder fashion after 5 h. On the other hand, when Jo2 antibody (100 #g) was injected into lpr mice, or anti-CD5 antibody (100 #g) was injected into the wild-type mice, no degradation of thymic chromosomal DNA was observed (Fig. 6) . These results indicated that the thymocytes are specifically sensitive in vivo to the apoptosis-inducing activity of the antiFas antibody, although it takes more time than apoptosis in the liver, which occurs within 2 h (8).
Discussion
Recently, Drappa et al. (25) , reported that most mouse thymocytes, including CD4-CD8-cells, express Fas with the highest levels being in CD4 § CD8 + thymocytes. Here, we examined Fas expression using three color method, and confirmed its expression in most thymocytes. However, unlike the report by Drappa et al. (25) , the most T-precursor cells (CD4-CD8-CD3-) did not express Fas, and little difference in the Fas expression levels was detected between DP and SP thymocytes. Our results suggest that the Fas expression is induced at the stage from CD3-CD41~176 to CD31~
+ and is thereafter expressed throughout the thymic development of mouse thymocytes. This distribution of Fas in mouse thymocytes is significantly different from that in human thymocytes (26, 27) , where Fas or APO-1 is not expressed (26) , or expressed weakly in CD4-CD8-DN and CD4+CD8 + DP thymocytes, but not in CD4 + CD8-or CD4-CD8 + SP cells (27) .
Since the loss-of-function mutations of Fas or Fas ligand causes lymphadenopathy and autoimmune disease (13, 14) , it is likely that the Fas system is involved in the apoptotic process during the development, maturation, or turnover of T cells. Here, we showed that the peritoneal administration of anti-Fas antibody into mice caused massive apoptosis in thymocytes. Since most thymocytes are comprised of CD4 § CD8 + DP cells, this agreed with the results obtained in vitro, which showed that the DP thymocytes are selectively sensitive to the cytolytic activity of the anti-Fas antibody. These results suggest a role of Fas in the thymic T cell development, since apoptosis of thymocytes mainly occurs in the DP stage (28) . However, the Fas-induced apoptosis is significantly different from the apoptosis induced by activation of thymocytes, which may or may not represent negative selection. The apoptosis induced by activation of thymocytes by PMA and ionomycin was blocked by inhibitors of protein or RNA synthesis, whereas Fas-induced apoptosis was enhanced by cycloheximide (Fig. 4) . Furthermore, thymocytes from lpr-mice which do not express Fas can be killed by activation with PMA and ionomycin, or anti-CD3 antibody (29, 30) . Negative selection occurs when T cell receptors of immature CD4 + CD8 + cells are engaged by exposure to selfantigen peptides complexed with self-MHC on thymic stroma cells (3) . Apoptosis of DP cells by anti-CD3 antibody was therefore proposed to reflect a model of negative selection (24, 31) . However, this model does not explain the negative selection observed in transgenic mice overexpressing Bcl-2 (32, 33) . In these mice, DP thymocytes are resistant against the anti-CD3-induced apoptosis in vitro, yet negative selection is not affected or only marginally disturbed in vivo. The Fas-mediated apoptosis is only partially inhibited by Bcl-2 (34), and Ipr or gld thymocytes undergo normal negative selection (35) . Taken together, there may be two apoptotic mechanisms for negative selection induced by TCK engagement; one pathway is sensitive to Bcl-2, while the other is resistant to Bcl-2, and Fas may be involved in the latter pathway. In addition to the apoptosis that occurs during negative selection, thymocytes which do not undergo positive selection die by apoptosis (programmed cell death) (1). Whether or not the Fas system is involved in this process remains to be elucidated.
As found in human naive mature T cells (36, 37) , CD4 + and CD8 + SP thymocytes could not be killed by anti-Fas antibody despite their high expression of Fas. These cells may be devoid of the apoptotic signal transduction system through Fas, or they express proteins that inhibit Fas-mediated apoptoffs. One candidate for such inhibitory protein is Bd-2 (38) which is abundantly expressed in SP thymocytes, but hardly expressed in DP thymocytes (39) . However, the overexpression of Bcl-2 only partially inhibits the Fas-mediated apoptosis in various cell types (34) . Since several Bcl-2-related proteins have been identified (40, 41) , it would be of interest to study whether they modulate Fas-mediated apoptosis.
Recently, Alderson et al. (42) have reported that costimulation of human thymocytes with anti-Fas antibody and anti-CD3 causes the Fas-dependent proliferation of thymocytes. With mouse thymocytes, we detected only the cytolytic activity of the anti-Fas antibody in the absence of anti-CD3 antibody, and not the growth-promoting activity. Natural Fas ligand also caused only apoptosis in mouse thymocytes (our unpublished results). It is possible that human and mouse thymocytes respond differently to the anti-Fas antibody or Fas ligand, or that stimulation of the TCR modified the Fasmediated signal transduction system in the thymocytes. However, it is more likely that the enhancement of the CD3-induced proliferation of human thymocytes by the anti-Fas antibody is due to the inhibition of the anti-CD3-induced apoptosis of mature thymocytes (such as CD4 + or CD8 + SP thymocytes) by the anti-Fas antibody, and expansion of the rescued cells with anti-CD3 antibody.
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